广泛性焦虑障碍

Professor of Psychopharmacology

Department of Psychiatry

University of Oxford

Oxford

UK

利益声明

PJC has acted as an expert witness in medico-legal cases involving anxiety and depressive disorders and their treatment. He is a member of the British Association for Psychopharmacology.

Professor Philip John Cowen would like to gratefully acknowledge Dr Christopher Gale, Dr Richard P. Swinson, Dr Elizabeth Hoge, and Dr Phebe Tucker, previous contributors to this topic.

利益声明

CG is an author of the Royal Australian and New Zealand College of Psychiatrists clinical practice guideline on social phobia, panic disorder, and generalised anxiety disorder. Otago University has commercial and research relationships with multiple pharmaceutical companies. He is an author of a number of references cited in this topic. RPS has personally received royalties for articles published in UpToDate (Wolters Kluwer) and the Compendium of Therapeutic Choices, 2nd edition (Canadian Pharmacists Association). EH is an author of a number of references cited in this topic. PT has conducted research for GlaxoSmithKline, Bristol-Myers Squibb, Wyeth Pharmaceuticals, Astra-Zeneca, Cephalon, Inc., and Ortho-McNeil. She has also consulted for Forest Pharmaceuticals and received honoraria from Pfizer, Inc. and Forest Pharmaceuticals.

Research Director

University of Alabama

School of Medicine Tuscaloosa Campus

College of Community Health Sciences

Tuscaloosa

AL

利益声明

LD declares that she has no competing interests.

Senior Clinical Lecturer

Division of Psychological Medicine and Clinical Neurosciences

Cardiff University

United Kingdom

利益声明

ADF declares that she has no competing interests.

Consultant in Paediatric Liaison Psychiatry

Royal Hospital for Children

Glasgow

United Kingdom

利益声明

EL declares that she has no competing interests.